6 TECH OUTLOOKMay - 2018Copyright © 2018 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.MAY 2018, Vol 04 - 04 Published by ValleyMedia Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com Editor-in-ChiefStacey SmithSalesVisualizerAsher BlakeAjay K DasEditorial StaffAaron Pierce Khyati Dubal Ava GarciaJenna Vegas Joshua ParkerJustin SmithMax Wilsonmax.wilson@pharmatechoutlook.comEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comCompanies that operate in the pharma and life sciences industry is actively pursuing different ways to put data into usage by seizing upon analytics opportunities to organize and apply data in a systematic way to thwart challenges related to patient care and drug development. Pharma companies are constantly looking for ways to improve the quality and speed of drug development. With the ability to integrate variety of data--from genomic research and clinical trials to data received from patients through their feedbacks--pharma companies can unlock valuable answers to key concerns such as true effectiveness of treatments to implement best practices in the drug development process.Big data and analytics helps drive insightful decisions on all aspects of the business from product planning, design, manufacturing to enhance collaboration in the ecosystem, boost cost optimization and drive competitive advantage. By implementing predictive analytics models that use internal and external data, pharma companies can tackle unforeseen events like drug shortages and evaluate potential risk factors such as elemental impurities in a drug. As new branches of science are being discovered, the knowledge of genomics and the broader implications of epigenomics is increasing that is augmenting the use of AI to gain valuable insights on these topics. Being under stringent regulatory controls, the pharma and life science industry can keep up with compliance through the application of analytics in the form of basic reporting and internal dashboard capabilities. To visualize the pharma and life science analytics ecosystem in a better way, this special edition brings together innovative service providers, changing trends, needs of the hour, and a glimpse into the future of pharma analytics. We hope the valuable insights from industry thought-leaders and the innovative solutions from leading as well as emerging companies featured in this edition will help you in making informed decisions for your analytics endeavors.Let us know your thoughts.Data Usage RedefinedTECH OUTLOOKTECH OUTLOOK*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffMAY, 2018PHARMA ANALYTICS SPECIALsales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405
< Page 5 | Page 7 >